BioScrip Receives URAC Accreditation in Specialty and Mail Service Pharmacy

BioScrip, Inc. (NASDAQ: BIOS) announced today that it has been awarded specialty pharmacy and mail service pharmacy accreditation from URAC, a Washington, D.C.-based health care accrediting organization that establishes quality standards for the health care industry.

Specialty pharmacy and mail service pharmacy offers comprehensive oversight of the distribution, clinical management, and reimbursement of oral, injectable, and IV drug products for chronic conditions. Specialty pharmaceuticals represent the fastest growing segment of drug spending due to new product approvals, high unit costs, and increasing use.